在两种商品重试排队库存系统中取代失败的项目,具有多元组件需求和假期中断的库存系统
相关实验视频
Updated: Aug 7, 2026

07:07
Errors as a Means of Reducing Impulsive Food Choice
Published on: June 5, 2016
8.7K
K Jeganathan1, V Anzen Koffer1, K Lakshmanan2
1Ramanujan Institute for Advanced Study in Mathematics, University of Madras, Chennai, 600005, India.
Heliyon
|January 31, 2024
概括
这项研究表明,在两种商品排队库存系统中替换失效的项目可以显著提高运营效率并降低成本. 战略替代政策在动态的商业环境中提高利能力.
科学领域:
- 运营研究 运营研究
- 排队理论 排队理论
- 库存管理 库存管理
背景情况:
- 动态的商业环境需要高效的库存管理,特别是替换失败的项目.
- 两种商品系统,包括免费物品和聚合存储,带来了独特的库存挑战.
- 服务器休假和多组件需求增加了队列库存模型的复杂性.
研究的目的:
- 分析一个两种商品重审队列库存系统,其中包括假期中断和替换政策.
- 评估物品更换对系统性能和运营效率的影响.
- 调查多元组件需求对客户到来和系统动态的影响.
主要方法:
- 制定一个依赖于水平的准出生和死亡过程.
- 使用Neuts和Rao的截断方法计算稳定状态概率.
- 系统稳定性条件和性能指标的推导 (例如预期成本,项目数量,客户).
主要成果:
- 与非替换模型相比,具有物品替换的系统显示出更高的效率.
- 多元组件需求显著提高了客户到达率.
- 参数灵敏度分析量化了各种因素对总成本和系统拥堵的影响.
结论:
- 实施战略替代政策对于优化两种商品排队库存系统至关重要.
- 了解需求模式和库存管理之间的相互作用是利能力的关键.
- 开发的模型为管理复杂的商业库存系统提供了有价值的见解.
相关概念视频
Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

